
Health Care Enjoys Mutual Funds' Affection

By Jim Cramer
About this article:
Lehman upgrades Schering-Plough because the numbers are too low on the Organon acquisition and the return of the cholesterol drug sales. Johnson & Johnson blows away the numbers and talks a good game. Genentech looked bad, but go read Adam Feuerstein's comments in the Columnist Conversation and you will get a sense of what's really going on.
When you put all of these together, you can see what's happening. This group has earnings momentum, and not just because of the weak dollar, which of course remains weak. Remember, mutual fund money has to go somewhere. Financials are too toxic to own.
So what happens? The mutual funds look for sectors to hide in and to overweight. Health care is one of those segments.
One of the things that people don't realize -- something that my friend Sheryl Skolnick, the best health care analyst I know who...

Or, call us at 1-866-321-TSCM (8726) Monday-Friday, 8 a.m.-6 p.m. ET.
Outside the U.S. and in Canada, call 1-212-321-5200.
|
|
|

 |

If you decide to subscribe and you're not completely satisfied with TheStreet.com RealMoney, just call us within the first 30 days of your subscription and we'll refund your full annual subscription price — guaranteed.
|
|
|
|
|
If you choose a 14-day free trial of RealMoney and you do NOT call to cancel within those 14 days, you will pay $129.95 — a $100 savings off the regular annual subscription price of $229.95. Unless you cancel before the end of that year, your subscription will automatically renew for another year at the then-current subscription price.
Offer applies only to new annual subscriptions, and is subject to change at any time. Void where prohibited.
If you choose a monthly subscription, you pay $34.95 per month. You will be notified if the current monthly rate of $34.95 changes at any time in the future.
TheStreet.com is a publisher. None of the contributors or their affiliates will provide you with personally tailored advice concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. From time to time, any or all of the contributors or their affiliates may hold positions in securities mentioned and they may trade for their own accounts. In cases where the position is held at the time of publication, appropriate disclosure is made.
© TheStreet.com, Inc., 14 Wall Street, 15th Floor, New York, NY 10005.
|